Ketamine’s pharmacokinetic and pharmacodynamic interactions with anticonvulsants, and their implications for psychiatry: A scoping review protocol

Hans-Christian Stein, Rebecca Strawbridge, Daniel Silman, Pietro Carmellini, Allan H. Young, Mario F. Juruena
doi: https://doi.org/10.1101/2023.02.09.23285702

Article Information

doi 
https://doi.org/10.1101/2023.02.09.23285702
History 
  • May 9, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Hans-Christian Stein1,*,
  2. Rebecca Strawbridge2,
  3. Daniel Silman2,
  4. Pietro Carmellini3,
  5. Allan H. Young2 and
  6. Mario F. Juruena2
  1. 1Department of Health Sciences, Università degli Studi di Milano, Milan, Italy
  2. 2Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
  3. 3Department of Mental Health and Sensory Organs, University of Siena Medical Center, Italy
  1. ↵*Corresponding author; email: hans.stein{at}unimi.it
Back to top
Posted May 09, 2023.
Download PDF
Data/Code
Email
Ketamine’s pharmacokinetic and pharmacodynamic interactions with anticonvulsants, and their implications for psychiatry: A scoping review protocol
Hans-Christian Stein, Rebecca Strawbridge, Daniel Silman, Pietro Carmellini, Allan H. Young, Mario F. Juruena
medRxiv 2023.02.09.23285702; doi: https://doi.org/10.1101/2023.02.09.23285702
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area